Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAPROXEN\NAPROXEN Cause Pulmonary fibrosis? 183 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Pulmonary fibrosis have been filed in association with NAPROXEN\NAPROXEN. This represents 15.8% of all adverse event reports for NAPROXEN\NAPROXEN.

183
Reports of Pulmonary fibrosis with NAPROXEN\NAPROXEN
15.8%
of all NAPROXEN\NAPROXEN reports
107
Deaths
126
Hospitalizations

How Dangerous Is Pulmonary fibrosis From NAPROXEN\NAPROXEN?

Of the 183 reports, 107 (58.5%) resulted in death, 126 (68.9%) required hospitalization, and 131 (71.6%) were considered life-threatening.

Is Pulmonary fibrosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAPROXEN\NAPROXEN. However, 183 reports have been filed with the FAERS database.

What Other Side Effects Does NAPROXEN\NAPROXEN Cause?

Fatigue (502) Mobility decreased (467) Off label use (462) Fibromyalgia (456) Folliculitis (449) Joint swelling (448) Psoriatic arthropathy (445) Glossodynia (434) General physical health deterioration (433) Hand deformity (431)

What Other Drugs Cause Pulmonary fibrosis?

METHOTREXATE (2,912) ADALIMUMAB (2,277) RITUXIMAB (2,192) ETANERCEPT (1,926) TOCILIZUMAB (1,886) ABATACEPT (1,828) HYDROXYCHLOROQUINE (1,740) LEFLUNOMIDE (1,731) PREDNISONE (1,692) INFLIXIMAB (1,595)

Which NAPROXEN\NAPROXEN Alternatives Have Lower Pulmonary fibrosis Risk?

NAPROXEN\NAPROXEN vs NAPROXEN\PSEUDOEPHEDRINE NAPROXEN\NAPROXEN vs NAPROXEN\SUMATRIPTAN NAPROXEN\NAPROXEN vs NARATRIPTAN NAPROXEN\NAPROXEN vs NASONEX NAPROXEN\NAPROXEN vs NATALIZUMAB

Related Pages

NAPROXEN\NAPROXEN Full Profile All Pulmonary fibrosis Reports All Drugs Causing Pulmonary fibrosis NAPROXEN\NAPROXEN Demographics